4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000142
EVP, Chf GL Pdt Str Ofcr sold 37,277 shares at an average $75.85 ($2,827,325)
- EVP, Chf GL Pdt Str Ofcr acquired 37,277 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jenne Kyle · EVP, Chf GL Pdt Str Ofcr
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +32,602 | $46.10 | $1,502,952 | 48,991 | D |
| 2026-03-10 | Sale : show line 2 in the form 10b5-1 | −21,191 | $75.50 | $1,599,963 | 27,800 | D |
| 2026-03-10 | Sale : show line 3 in the form 10b5-1 | −16,086 | $76.30 | $1,227,362 | 11,714 | D |
| 2026-03-10 | Exercise or conversion : show line 4 in the form 10b5-1 | +4,675 | $34.69 | $162,176 | 16,389 | D |
| Open-market sales · 37,277 sh · avg $75.85 · $2,827,325 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-10 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −4,675 | 14,025 | D |
| 2026-03-10 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −32,602 | 32,601 | D |
Loading xslF345X05/edgardoc.xml…